DRY PRODUCTS, PASTES AND LIQUIDS

gien-pelliculage2.jpg

Built in 1963 at the instigation of the Rhône Poulenc laboratory, the Gien site was acquired by Pierre Fabre in 1993. Since then, it has continued to evolve and has doubled its production capacity. Today, it is the group’s most important pharmaceutical production site. It manufactures and packages dry (hard capsules, tablets, sachets), paste and liquid forms under pharmaceutical, dermo-cosmetic, and medical device status. It makes its expertise available to third-party laboratories and offers processing activities for the following pharmaceutical forms: dry forms, liquids and pastes.

The site is approved by health authorities in various regions: ANSM (France), EMA (Europe) and ANVISA (Brazil), among others.